Topic: Supplement Issue of the 2027 XiaoXiang-International Cardiology Conference (X²-ICC 2027)

The XiaoXiang-International Cardiology Conference (X²-ICC 2027) will be held from March 5 to 7, 2027, in Changsha, serving as an important international platform for interdisciplinary exchange in cardiovascular medicine. The conference brings together cardiologists, physicians, researchers, technicians, nurses, general practitioners, and other healthcare professionals to share recent advances and foster academic collaboration.

As a Conference Supplement Issue, this collection aims to highlight key scientific contributions associated with X²-ICC 2027, reflecting the most recent progress, innovative findings, and translational developments presented during the meeting.

The scope of this issue includes, but is not limited to, atherosclerosis and coronary artery disease, cardiovascular metabolism, pulmonary vascular diseases, interventional cardiology, cardiovascular immunology, inflammation, and cardiac remodeling. We also particularly welcome submissions on emerging and frontier topics such as precision medicine, artificial intelligence in cardiology, structural heart disease, and novel therapeutic strategies.

By assembling high-quality contributions from leading experts and active researchers participating in the conference, this supplement seeks to capture the current landscape of cardiovascular research and to promote the translation of scientific discoveries into clinical practice.

Atherosclerosis, coronary artery disease, cardiovascular metabolism, pulmonary vascular diseases, interventional cardiology, cardiovascular immunology, inflammation, and cardiac remodeling